Published in J Extra Corpor Technol on March 01, 2009
Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med (2001) 11.56
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Brain swelling in first hour after coronary artery bypass surgery. Lancet (1993) 3.80
Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg (1996) 3.77
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA (1999) 3.51
Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis (2000) 3.03
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood (1995) 2.96
Genetics of susceptibility to human infectious disease. Nat Rev Genet (2001) 2.80
Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med (1981) 2.63
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med (2003) 2.37
Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery. J Thorac Cardiovasc Surg (2003) 2.25
Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol (2003) 2.22
A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med (1996) 2.21
The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg (2002) 2.20
Genetics and ischaemic stroke. Brain (2000) 2.17
Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest (1997) 2.07
The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation (2003) 2.03
Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth (2004) 1.96
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm (1997) 1.91
Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab (1999) 1.87
Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. Ann Thorac Surg (1994) 1.80
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab (2000) 1.67
Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis (1996) 1.64
Is there cognitive decline 1 year after CABG? Comparison with surgical and nonsurgical controls. Neurology (2005) 1.63
Protein C -1641 AA is associated with decreased survival and more organ dysfunction in severe sepsis. Crit Care Med (2007) 1.63
An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol (2005) 1.59
Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass. Ann Thorac Surg (1998) 1.59
The impact of aortic manipulation on neurologic outcomes after coronary artery bypass surgery: a risk-adjusted study. Ann Thorac Surg (2004) 1.56
Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol (2005) 1.55
Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J Pharmacol Exp Ther (2002) 1.52
Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. Ann Thorac Surg (2000) 1.51
Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis (1995) 1.51
Postoperative hypoxia is a contributory factor to cognitive impairment after cardiac surgery. J Thorac Cardiovasc Surg (2003) 1.49
Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg (1997) 1.48
Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study. Can J Anaesth (2004) 1.48
The effect of apolipoprotein E genotype on neuron specific enolase and S-100beta levels after cardiac surgery. Anesth Analg (2004) 1.46
Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation (2000) 1.42
Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med (1999) 1.40
Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett (2004) 1.34
Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol (2000) 1.32
Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones (1997) 1.21
Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience (2005) 1.17
Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: timing of dose is important. J Thorac Cardiovasc Surg (1999) 1.16
Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg (1998) 1.09
Genetic factors contribute to bleeding after cardiac surgery. J Thromb Haemost (2005) 1.08
Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol (1995) 1.08
Brain microemboli associated with cardiopulmonary bypass: a histologic and magnetic resonance imaging study. Ann Thorac Surg (1995) 1.07
Preexisting cognitive impairment in women before cardiac surgery and its relationship with C-reactive protein concentrations. Anesth Analg (2006) 1.06
Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg (1999) 1.05
The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution. Ann Surg (1988) 1.05
Hypoxia-inducible factor-1 (HIF-1). Crit Care Med (2005) 1.03
Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest (2005) 1.03
Genotype and interleukin-10 responses after cardiopulmonary bypass. Br J Anaesth (2003) 1.02
Factor XIII val34leu and the risk of myocardial infarction. Haematologica (2000) 1.02
Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem (2006) 1.01
Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg (1986) 1.01
The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg (2004) 1.01
Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation (2002) 1.00
The erythropoietin neuroprotective effect: assessment in CABG surgery (TENPEAKS): a randomized, double-blind, placebo controlled, proof-of-concept clinical trial. Stroke (2009) 0.99
Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int (2005) 0.98
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol (2000) 0.97
Cognitive change 5 years after coronary artery bypass surgery. Health Psychol (2003) 0.97
Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke (2005) 0.96
Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth (1999) 0.95
Cerebral ischemic injury and cognitive impairment after off-pump and on-pump coronary artery bypass grafting surgery. Ann Thorac Surg (2005) 0.95
Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol (2000) 0.95
Genetic polymorphisms of apolipoprotein E4 and tumor necrosis factor beta as predisposing factors for increased inflammatory cytokines after cardiopulmonary bypass. J Thorac Cardiovasc Surg (2004) 0.94
Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke (2005) 0.94
Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J Thorac Cardiovasc Surg (2005) 0.93
Interleukin-6 levels in serum and lung lavage fluid of children undergoing open heart surgery correlate with postoperative morbidity. Intensive Care Med (1998) 0.93
Pattern and significance of cerebral microemboli during coronary artery bypass grafting. Ann Thorac Surg (1998) 0.91
Cardiopulmonary bypass-induced inflammation: is it important? J Cardiothorac Vasc Anesth (1998) 0.90
Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: the role of tissue injury by surgical incision. Chest (1999) 0.89
Cerestat and other NMDA antagonists in ischemic stroke. Neurology (1997) 0.89
Brain damage during cardiopulmonary bypass. Ann Thorac Surg (1998) 0.89
Cerebral emboli and serum S100beta during cardiac operations. Ann Thorac Surg (1998) 0.89
Retinal microembolism during cardiopulmonary bypass demonstrated by fluorescein angiography. Lancet (1986) 0.88
Pathophysiology of cardiopulmonary bypass: current issues. J Card Surg (1990) 0.86
Positive and negative modulation of the GABA(A) receptor and outcome after traumatic brain injury in rats. Brain Res (2000) 0.85
Fixing the heart: must the brain pay the price? Circulation (2004) 0.85
Expression of tumor necrosis factor-alpha and intercellular adhesion molecule-1 after focal cerebral ischemia in interleukin-1beta converting enzyme deficient mice. J Cereb Blood Flow Metab (1999) 0.83
Inhibition of microarterial thrombosis by activated protein C in a rabbit model. Thromb Haemost (1994) 0.82
A single nucleotide polymorphism of macrophage migration inhibitory factor is related to inflammatory response in coronary bypass surgery using cardiopulmonary bypass. Eur J Cardiothorac Surg (2006) 0.82
The protein C system in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg (1987) 0.82
Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem (1995) 0.82
Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries. Thromb Res (1991) 0.81
Low doses of activated protein C delay arterial thrombosis in rats. Thromb Res (1990) 0.81
Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. Brain Res Mol Brain Res (1999) 0.81
Relationship between white cell count, neuropsychologic outcome, and microemboli in 161 patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg (2006) 0.80
Genetic risk factors for venous thrombosis. Mol Genet Metab (2000) 0.80
Effect of piracetam on cognitive performance in patients undergoing bypass surgery. Pharmacopsychiatry (2003) 0.80
Genetic epidemiology utilizing the adoption method: studies of obesity and of premature death in adults. Scand J Soc Med (1991) 0.79
Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction. Ann Thorac Surg (2003) 0.79
Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Ann Thorac Surg (2001) 0.79
Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke (2003) 0.78
Simultaneous glutamate and GABA(A) receptor agonist administration increases calbindin levels and prevents hippocampal damage induced by either agent alone in a model of perinatal brain injury. Brain Res Dev Brain Res (2005) 0.78
Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis. Infection (2000) 0.78
Effect of low-dose methyl prednisolone on serum cytokine levels following extracorporeal circulation. Perfusion (1999) 0.78
Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med (2008) 11.00
Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med (2011) 6.79
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet (2010) 3.15
A multibiomarker-based outcome risk stratification model for adult septic shock*. Crit Care Med (2014) 2.94
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med (2009) 2.77
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med (2008) 2.64
Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology (2002) 2.59
S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res (2008) 2.54
Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19
Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults. Crit Care Med (2005) 1.99
Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med (2014) 1.97
Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res (2006) 1.96
Extracellular heat shock protein 70 induces cardiomyocyte inflammation and contractile dysfunction via TLR2. Circ J (2011) 1.73
Clinical review: Update on hemodynamic monitoring--a consensus of 16. Crit Care (2011) 1.62
Lack of agreement between thermodilution and fick cardiac output in critically ill patients. Chest (2002) 1.60
Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Crit Care Med (2011) 1.54
A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. Am J Respir Crit Care Med (2014) 1.53
Agreement in electrocardiogram interpretation in patients with septic shock. Crit Care Med (2011) 1.52
Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine. Crit Care (2013) 1.46
Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia. Crit Care Med (2007) 1.45
Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock. Crit Care Med (2014) 1.44
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest (2003) 1.43
The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med (2009) 1.34
Bench-to-bedside review: Association of genetic variation with sepsis. Crit Care (2009) 1.31
IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis. Crit Care (2011) 1.23
The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg (2005) 1.20
Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock (2012) 1.15
Improved arterial oxygenation with biologically variable or fractal ventilation using low tidal volumes in a porcine model of acute respiratory distress syndrome. Am J Respir Crit Care Med (2002) 1.09
Cardiac ICAM-1 mediates leukocyte-dependent decreased ventricular contractility in endotoxemic mice. Cardiovasc Res (2006) 1.08
beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. Am J Respir Crit Care Med (2009) 1.06
The association of interleukin 6 haplotype clades with mortality in critically ill adults. Arch Intern Med (2005) 1.06
One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care (2013) 1.06
Identification of a nonsynonymous polymorphism in the SVEP1 gene associated with altered clinical outcomes in septic shock. Crit Care Med (2015) 1.04
Interleukin-10 haplotype associated with increased mortality in critically ill patients with sepsis from pneumonia but not in patients with extrapulmonary sepsis. Chest (2005) 1.03
Microvascular resuscitation as a therapeutic goal in severe sepsis. Crit Care (2005) 1.01
Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury. Crit Care (2006) 1.00
Novel regulatory mechanism of cardiomyocyte contractility involving ICAM-1 and the cytoskeleton. Am J Physiol Heart Circ Physiol (2004) 1.00
The prediction of adverse maternal outcomes in preeclampsia. J Obstet Gynaecol Can (2004) 0.99
Microarray genotyping resource to determine population stratification in genetic association studies of complex disease. Biotechniques (2004) 0.98
Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice. Crit Care (2009) 0.97
A single nucleotide polymorphism in NF-κB inducing kinase is associated with mortality in septic shock. J Immunol (2011) 0.97
Best vasopressor for advanced vasodilatory shock: should vasopressin be part of the mix? Intensive Care Med (2010) 0.95
Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Respir Crit Care Med (2013) 0.95
Mechanisms of beta-receptor stimulation-induced improvement of acute lung injury and pulmonary edema. Crit Care (2004) 0.94
Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism. Crit Care (2008) 0.94
Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. CMAJ (2006) 0.93
Myocardial hypoxia-inducible HIF-1alpha, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia. Am J Physiol Heart Circ Physiol (2007) 0.92
The Toll-like receptor 9 ligand CPG-C attenuates acute inflammatory cardiac dysfunction. Shock (2011) 0.91
Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R. Resuscitation (2008) 0.90
Vasopressin and its immune effects in septic shock. J Innate Immun (2010) 0.89
Comparing the prognostic performance of ASSIST to interleukin-6 and procalcitonin in patients with severe sepsis or septic shock. Biomarkers (2015) 0.88
Severe acute respiratory distress syndrome (SARS): a critical care perspective. Crit Care Med (2003) 0.88
Molecular mechanisms of sepsis. Contrib Microbiol (2011) 0.88
Vasopressin in the ICU. Curr Opin Crit Care (2004) 0.87
MACGT: multi-dimensional automated clustering genotyping tool for analysis of microarray-based mini-sequencing data. Bioinformatics (2006) 0.87
Update in sepsis 2012. Am J Respir Crit Care Med (2013) 0.86
Cytokines and signaling molecules predict clinical outcomes in sepsis. PLoS One (2013) 0.85
The role of echocardiography in hemodynamic monitoring. Curr Opin Crit Care (2009) 0.85
Endotoxemia increases the clearance of mPEGylated 5000-MW quantum dots as revealed by multiphoton microvascular imaging. J Biomed Opt (2007) 0.85
A nonsynonymous polymorphism of IRAK4 associated with increased prevalence of gram-positive infection and decreased response to toll-like receptor ligands. J Innate Immun (2011) 0.84
Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Curr Opin Crit Care (2008) 0.84
Bad medicine: low-dose dopamine in the ICU. Chest (2003) 0.83
Protein C rs2069912 C allele is associated with increased mortality from severe sepsis in North Americans of East Asian ancestry. Hum Genet (2008) 0.82
San Antonio Vasopressin in Shock Symposium report. Resuscitation (2010) 0.82
The evaluation and management of shock. Clin Chest Med (2003) 0.81
A practical approach to goal-directed echocardiography in the critical care setting. Crit Care (2014) 0.81
Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis. J Innate Immun (2016) 0.81
Vasoactive drugs for vasodilatory shock in ICU. Curr Opin Crit Care (2009) 0.81
NIRS: a standard of care for CPB vs. an evolving standard for selective cerebral perfusion? J Extra Corpor Technol (2009) 0.80
Arginine vasopressin in the treatment of vasodilatory septic shock. Best Pract Res Clin Anaesthesiol (2008) 0.80
Deeper understanding of mechanisms contributing to sepsis-induced myocardial dysfunction. Crit Care (2014) 0.79
S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architecture. PLoS One (2012) 0.79
AA genotype of IL-8 -251A/T is associated with low PaO(2)/FiO(2) in critically ill patients and with increased IL-8 expression. Respirology (2012) 0.78
Applied neuromonitoring and improving CNS outcomes. Semin Cardiothorac Vasc Anesth (2005) 0.78
Clinical review: Guyton--the role of mean circulatory filling pressure and right atrial pressure in controlling cardiac output. Crit Care (2010) 0.78
Update in sepsis and pulmonary infections 2013. Am J Respir Crit Care Med (2014) 0.78
Acute hypervolaemia improves arterial oxygen pressure in athletes with exercise-induced hypoxaemia. Exp Physiol (2003) 0.77
Fluid choices impact outcome in septic shock. Curr Opin Crit Care (2014) 0.77
Three-dimensional capillary geometry in gut tissue. Microsc Res Tech (2003) 0.77
Acute organ injury is associated with alterations in the cell-free plasma transcriptome. Intensive Care Med Exp (2014) 0.77
Fibrinogen-beta gene haplotype is associated with mortality in sepsis. J Infect (2006) 0.77
VPS13D Gene Variant Is Associated with Altered IL-6 Production and Mortality in Septic Shock. J Innate Immun (2015) 0.76
Elevated Plasma Angiopoietin-2 Levels Are Associated With Fluid Overload, Organ Dysfunction, and Mortality in Human Septic Shock. Crit Care Med (2016) 0.76
Activated protein C: beyond 28 days. Crit Care Med (2004) 0.76
Sepsis and the innate-like response. Intensive Care Med (2013) 0.76
TNFAIP2 Inhibits Early TNFα-Induced NF-x03BA;B Signaling and Decreases Survival in Septic Shock Patients. J Innate Immun (2015) 0.76
Multiple Organ Dysfunction Score Is Superior to the Obstetric-Specific Sepsis in Obstetrics Score in Predicting Mortality in Septic Obstetric Patients. Crit Care Med (2017) 0.75
Aging and the intramyocardial inflammatory response. Crit Care (2014) 0.75
Expanding our thinking regarding early goal-directed therapy. Crit Care Med (2012) 0.75
Correction: Lipopolysaccharide Is Cleared from the Circulation by Hepatocytes via the Low Density Lipoprotein Receptor. PLoS One (2016) 0.75
A step forward toward the clinical application of palifermin for acute respiratory distress syndrome? Am J Respir Crit Care Med (2014) 0.75
Predicting mortality in patients with acute lung injury. Am J Respir Crit Care Med (2011) 0.75
Metabolic changes in cardiomyocytes during sepsis. Crit Care (2013) 0.75
Pro/con clinical debate: are steroids useful in the management of patients with septic shock? Crit Care (2002) 0.75
Neurocognitive outcomes: the year in review. Curr Opin Anaesthesiol (2005) 0.75
Novel polymorphism of interleukin-18 associated with greater inflammation after cardiac surgery. Crit Care (2009) 0.75
Neutrophil apoptosis in preeclampsia, do steroids confound the relationship? J Obstet Gynaecol Res (2004) 0.75
Short-Term Organ Dysfunction Is Associated With Long-Term (10-Yr) Mortality of Septic Shock. Crit Care Med (2016) 0.75
Increased Ratio of Visceral to Subcutaneous Adipose Tissue in Septic Patients Is Associated With Adverse Outcome. Crit Care Med (2016) 0.75